miR-143-3p regulates cell proliferation and apoptosis by targeting IGF1R and IGFBP5 and regulating the Ras/p38 MAPK signaling pathway in rheumatoid arthritis.

It has been demonstrated that the deregulation of microRNAs (miRNAs) affects the development of rheumatoid arthritis (RA). The primary objective of the current study was to determine the role of miR‑143‑3p in the progression of RA. The expression of miR‑143‑3p in synovium taken from patients with RA was assessed by reverse transcription‑quantitative polymerase chain reaction. The expression of miR‑143‑3p was higher in synovium tissues of RA than that of osteoarthritis (OA). The decreased expression of miR‑143‑3p suppressed cell proliferation and promoted apoptosis in vitro. In addition, inhibition of miR‑143‑3p decreased levels of inflammatory cytokines, as determined by an enzyme‑linked immunosorbent assay. IGF1R and IGFBP5 were found to be the target genes of miR‑143‑3p, and it was demonstrated that miR‑143‑3p regulated the proliferation and apoptosis of MH7A cells by targeting IGF1R and IGFBP5. Furthermore, TNF‑α treatment stimulated the Ras/p38 mitogen activated protein kinase (MAPK) signaling pathway, whereas miR‑143‑3p inhibition suppressed it. The results of the current study indicate that miR‑143‑3p may regulate cell proliferation and apoptosis by targeting IGF1R and IGFBP5 expression and regulating the Ras/p38 MAPK signaling pathways. Therefore, miR‑143‑3p may be a novel therapeutic target in RA. [ABSTRACT FROM AUTHOR]